Publikationen im NUM

Wygrecka M, Birnhuber A, Seeliger B, Michalick L, Pak O, Schultz A, Schramm F, Zacharias M, Gorkiewicz G, David S, Welte T, Schmidt J, Weissmann N, Schermuly R, Barreto G, Schaefer L, Markart P, Brack M, Hippenstiel S, Kurth F, Sander L, Witzenrath M, Kuebler W, Kwapiszewska G, Preissner K. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 2022; 6(3):1074—1087.      [DOI] 

Buhr L, Schicktanz S, Nordmeyer E. Attitudes Toward Mobile Apps for Pandemic Research Among Smartphone Users in Germany: National Survey. JMIR Mhealth Uhealth. 2022; 10(1):e31857.      [DOI] 

Schulz SR, et al . Augmented Neutralization of SARS-CoV-2 Omicron Variant by Boost Vaccination and Monoclonal Antibodies. European journal of immunology. 2022;      [DOI] 

Schmid B, Griesel M, Fischer A, Romero CS, Metzendorf M, Weibel S, Fichtner F. Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis. J Clin Med. 2022; 11(2):391.      [DOI] 

Demleitner AF, Wolff A, Erber J, et al . Best practice approaches to outpatient management of people living with Parkinson's disease during the COVID-19 pandemic. J Neural Transm (Vienna). 2022; 129(11):1377-1385.      [DOI] 

Lingscheid T, Lippert L, Hillus D, Kruis T, Thibeault C, Helbig E, Tober-Lau P, Pfäfflin F, Müller-Redetzky H, Witzenrath M, Zoller T, Uhrig A, Opitz B, Suttorp N, Kramer T, Sander L, Stegemann M, Kurth F. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study. Infection. 2022; 50(6):1441—1452.      [DOI] 

Walker A, Houwaart T, Finzer P, Ehlkes L, Tyshaieva A, Damagnez M, Strelow D, Duplessis A, Nicolai J, Wienemann T, Tamayo T, Kohns Vasconcelos M, Hülse L, Hoffmann K, Lübke N, Hauka S, Andree M, Däumer MP, Thielen A, Kolbe-Busch S, Göbels K, Zotz R, Pfeffer K, Timm J, Dilthey AT. Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022; 74(6):1039—1046.      [DOI] 

Schmidt M, Gebauer S, Bartholmes A, Kadioglu D, Kleesiek J, Hamm B, Vogl T, Penzkofer T, Bucher A, Storf H. CODEX Meets RACOON - A Concept for Collaborative Documentation of Clinical and Radiological COVID-19 Data. Stud Health Technol Inform. 2022;      [DOI] 

Dulovic A, et al . Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Frontiers in Immunology. 2022; 13828053.      [DOI] 

Georg P, Astaburuaga-García R, Bonaguro L, Brumhard S, Michalick L, Lippert ea. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022; 185493—512.e425.

Brandner J, Boor P, Borcherding L, et al . Contamination of personal protective equipment during COVID-19 autopsies. Virchows Arch. 2022; 1-10.      [DOI] 

Mardiko AA, Heinemann S, Bludau A, Kaba HEJ, Leha A, Maltzahn N, Mutters NT, Leistner R, Mattner F, Scheithauer S. COVID-19 vaccination strategy for hospital staff in Germany: a cross-sectional study in March-April 2021. The Journal of hospital infection. 2022; 12687—92.      [DOI] 

Scheithauer S, Bludau A, Heinemann S, Anton M, Knolle P. COVID-19-Impfstrategien für Beschäftigte deutscher Kliniken: Ergebnisse einer Befragung von Leitungen der (Krankenhaus\hbox-)Hygiene im Rahmen des B-FAST-Projektes. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2022; 65(12):1299—1306.      [DOI] 

Radbruch L, Bausewein C. Covid-19: Was die Palliativmedizin leisten kann. Rheinisches Ärzteblatt. 2022; (6):

Tober-Lau P, et al . Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections. Emerging infectious diseases. 2022; 28      [DOI] 

Meyer-Arndt L, et al . Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly. Journal of immunology. 2022; 2081001–1005.      [DOI] 

Chen H, et al . Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med. 2022; 14e14182.      [DOI] 

Chen H, Maul‐Pavicic A, Holzer M, et al . Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel. EMBO Mol Med. 2022; 14(1):      [DOI]      [Datei] 

Tauchert M, Bernemann I, Kühn-Steven A, Kopfnagel V, Kunze S, Illig T, Anton G. Digital knowledge management within the NAPKON study. Abstract. 11. Nationales Biobanken Symposium. 2022. Not available. 2022;

Vanshylla K, et al . Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults. The Lancet Infectious Diseases. 2022; 22445–446.      [DOI] 

Koerber N, Priller A, Yazici S, et al . Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun. 2022; 13(1):      [DOI] 

Akbil B, Meyer T, Stubbemann P, Thibeault C, Staudacher O, Niemeyer D, Jansen J, Mühlemann B, Doehn J, Tabeling C, Nusshag C, Hirzel C, Sanchez DS, Nieters A, Lother A, Duerschmied D, Schallner N, Lieberum JN, August D, Rieg S, Falcone V, Hengel H, Kölsch U, Unterwalder N, Hübner R, Jones TC, Suttorp N, Drosten C, Warnatz K, Spinetti T, Schefold JC, Dörner T, Sander LE, Corman VM, Merle U, Group P, Kurth F, Bernuth H, Meisel C, Goffinet C. Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies. J. Clin. Immunol.. 2022 Aug.; 42(6):1111—1129.      [DOI]  [Pubmed] 

Akbil B, et al . Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies. Journal of Clinical Immunology. 2022;      [DOI] 

Pietzner M, Chua RL, Wheeler E, Jechow K, Radbruch H, Trump ea. ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19. medRxiv. 2022;      [DOI] 

Hopff S, Tilch K, Kraus M, Lorenz-Depiereux L, Anton G, Appel K, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, others . Ethical and coordinative challenges in setting up a national cohort study exemplified by the German National Pandemic Cohort Network (NAPKON). Abstract ECCMID 2022. 2022;

Antoniou K, Vasarmidi E, Russell A, Andrejak C, Crestani B, Delcroix M, Dinh-Xuan A, Poletti V, Sverzellati N, Vitacca M, Witzenrath M, Tonia T, Spanevello A. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022; 60(2):2102174.      [DOI] 

Krüger L, Klein J, Tobian F, others . Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2. Infection. 2022; 50      [DOI]      [Datei] 

Hoffmann M, et al . Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy. mBio. 2022;      [DOI] 

Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, Haeusler KG, Heuschmann PU, Hildesheim H, Hinz A, Hopff S, Horn A, Krawczak M, Krist L, Kudelka J, Lieb W, Maetzler C, Mehnert-Theuerkauf A, Montellano FA, Morbach C, Schmidt S, Schreiber S, Steigerwald F, Störk S, Maetzler W, Finke C. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine. 2022 Nov.; 53(101651):101651.      [DOI]  [Pubmed] 

Ameratunga R, Woon S, Sheppard M, et al . First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction. J Clin Immunol. 2022;      [DOI] 

Von Stillfried S, Bülow R, Röhrig R, Boor P, Collaborators D. First report from the German COVID-19 autopsy registry. The Lancet Regional Health - Europe. 2022; 100330.      [DOI] 

Steinbeis F, Knape P, Mittermaier M, Helbig E, Tober-Lau P, Thibeault C, Lippert L, Xiang W, Müller-Plathe M, Steinbrecher S, others . Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents. Respir Med. 2022; 202106968.      [DOI] 

Rosenau L, Majeed RW, Ingenerf J, Kiel A, Kroll B, Köhler T, Prokosch H, Gruendner J. Generation of a Fast Healthcare Interoperability Resources (FHIR)-based Ontology for federated Feasibility Queries in the context of COVID-19: An automated approach. JMIR Med Inform. 2022 Apr.; 10(4):e35789.      [DOI] 

Kühnapfel A, Horn K, Klotz U, Kiehntopf M, Rosolowski M, Loeffler M, Ahnert P, Suttorp N, Witzenrath M, Scholz M. Genetic Regulation of Cytokine Response in Patients with Acute Community-Acquired Pneumonia. Genes (Basel). 2022; 13(1):111.      [DOI] 

Dannebaum R, Suwalski P, Asgharian H, Du ZG, Lin H, Weiner J, Holtgrewe M, Thibeault C, Müller M, Wang X, others . Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19. EClinicalMedicine. 2022; 48101438.      [DOI] 

Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel S, Wyler E, Baumgardt M, Löwa A, Hoffmann K, others . Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J. 2022; 60(6):2102725.      [DOI] 

Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel ea. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J. 2022; 60(6):2102725.      [DOI] 

Wolff AW, Haller B, Demleitner AF, Westenberg E, Lingor P. Impact of the COVID-19 pandemic on patients with Parkinson's Disease from the perspective of treating physicians-A nationwide cross-sectional study. Brain Sci.. 2022 Mä.; 12(3):353.

Bernatz S, Afat S, Othman AE, et al . Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave. Fortschr Röntgenstr. 2022; 19470-82.

Sedlmayr B, Sedlmayr M, Schüttler C, et al . Improving collaborative COVID-19 research of University Hospitals in Germany: Formative usability evaluation of the CODEX-Feasibility Portal. Appl Clin Inform. 2022; 13400—409.      [DOI] 

Wratil PR, Schmacke NA, Osterman A, et al . In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. Infection. 2022; 50      [DOI] 

Dragano N, Reuter M, Peters A, Engels M, Schmidt B, Greiser K, Bohn B, Riedel-Heller S, Karch A, Mikolajczyk R, Krause G, Lang O, Panreck L, Rietschel M, Brenner H, Fischer B, Franzke C, Gastell S, Holleczek B, Jöckel K, Kaaks R, Keil T, Kluttig A, Kuß O, Legath N, Leitzmann M, Lieb W, Meinke-Franze C, Michels K, Obi N, Pischon T, Feinkohl I, Rospleszcz S, Schikowski T, Schulze M, Stang A, Völzke H, Willlich S, Wirkner K, Zeeb H, Ahrens W, Berger K. Increase in mental disorders during the COVID-19 pandemic - the role of occupational and financial strains. An analysis of the German National Cohort (NAKO) Study. Deutsches Ärzteblatt International. 2022; 119179–187.      [DOI] 

Bludau A, Heinemann S, Mardiko AA, Kaba HEJ, Leha A, Maltzahn N, Mutters NT, Leistner R, Mattner F, Scheithauer S. Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals: a cross-sectional study in March-April 2021. The Journal of hospital infection. 2022; 12528—36.      [DOI] 

Houwaart T, Belhaj S, Tawalbeh E, Nagels D, Fröhlich Y, Finzer P, Ciruela P, Sabrià A, Herrero M, Andrés C, Antón A, Benmoumene A, Asskali D, Haidar H, Dahlen J, Nicolai J, Stiller M, Blum J, Lange C, Adelmann C, Schroer B, Osmers U, Grice C, Kirfel PP, Jomaa H, Strelow D, Hülse L, Pigulla M, Kreuzer P, Tyshaieva A, Weber J, Wienemann T, Kohns Vasconcelos M, Hoffmann K, Lübke N, Hauka S, Andree M, Scholz CJ, Jazmati N, Göbels K, Zotz R, Pfeffer K, Timm J, Ehlkes L, Walker A, Dilthey AT. Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2022; 27(43):      [DOI] 

Müller A, Haneke H, Kirchberger V, Mastella G, Dommasch M, Merle U, Heinze O, Siegmann A, Spinner C, Buiatti A, Laugwitz K, Schmidt G, Martens E. Integration of mobile sensors in a telemedicine hospital system: Remote-monitoring in COVID-19 patients. Journal of Public Health. 2022; 30(1):93—97.      [DOI] 

Kantauskaite M, et al . Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2022; 22634–639.      [DOI] 

Oorschot , others . Interaktive Homepage für Trauernde in Pandemiezeiten. Schmerz, Nervenarzt, Forum DKG, Urologe, Onkologe. 2022;

Dönges P, Wagner J, Contreras S, Iftekhar EN, Bauer S, Mohr SB, Dehning J, Valdez AC, Kretzschmar M, Mäs M, Nagel K, Priesemann V. Interplay Between Risk Perception, Behavior, and COVID-19 Spread. Frontiers in Physics. 2022; 10842180.      [DOI] 

Stillfried S, Bülow R, Röhrig R, Meybohm P, Boor P. Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report. Critical care (London, England). 2022; 2683.      [DOI] 

Pauli B, Strupp J, Schloesser K, others . It’s like standing in front of a prison fence – Dying during the SARS-CoV2 pandemic: A qualitative study of bereaved relatives’ experiences. Palliative Medicine. 2022;      [DOI]